Completed
A First-in-human Single and Repeated Dose Escalation Study of SAR442501 in Healthy Adults Subjects
NCT05846009
- Conditions
- Bone Diseases, Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +4 more
- Locations
-
- Investigational site Newark, New Jersey, United States